Department of Psychiatry, Faculty of Medicine, University of Geneva (UNIGE), Geneva, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
Division of Clinical Pharmacology & Toxicology, Multidisciplinary Pain Centre (MPC), University Hospitals of Geneva (HUG), Switzerland.
J Psychosom Res. 2022 Jun;157:110788. doi: 10.1016/j.jpsychores.2022.110788. Epub 2022 Mar 19.
In psychiatric literature, few original studies exist on the topic of demoralization in suicide. In this review, we aim to identify original studies on suicidal ideation (SI)/suicidal behavior (SB) and demoralization in populations of community-dwellers and patients with somatic or psychiatric disorders.
We employed a systematic approach that followed PRISMA guidelines, searching through four major electronic databases (PubMed/MEDLINE, Scopus, Science Direct, and PsychINFO) for relevant titles/abstracts published from January 1980-June 2021. We included original studies that explicitly mentioned the investigation of a potential association between SI/SB and demoralization.
A total of 18 studies met our inclusion criteria. Their synthesis revealed that demoralization can be associated with SI/SB in a wide range of populations (community dwellers, patients with somatic or psychiatric disorders) and lead to significantly higher suicide risk (odds ratios of >6 were encountered in community dwellers experiencing financial hardship or isolation). Moreover, demoralization alone (about half the patients who were demoralized did not meet the criteria for an affective disorder nor were they clinically depressed) or together with depression has been identified as a major risk factor for SI/SB. Regarding the crucial issue of progression from SI to SA, in the context of the "ideation-to-action" frame, some authors found that the interaction of demoralization and over-arousal could be a useful predictor for this progression, while others found that depression alone was sufficient to differentiate attempters from non-attempters or the interaction with shutdown (helplessness and low positive emotions).
These results emphasize the possibility to identify demoralization as an independent risk factor for suicide. In patients with psychiatric disorders, the association between demoralization and SI/SB may be transnosographic. Overall, from the clinical implications perspective, our findings highlight that: i. Assessment of demoralization may contribute to a more comprehensive suicide risk detection. This appears particularly relevant in Emergency Departments (EDs) where heterogeneous population typologies are usually admitted and a clinical diagnosis of depression is often difficult to be defined. ii. Additionally, since meaninglessness is considered one of the demoralization subcomponents, meaning-centered psychotherapeutic approaches prove to be indicated and they can be initiated already at the EDs upon first contact with the patient. Further studies are necessary to confirm these findings.
在精神医学文献中,关于自杀患者道德低落的原创研究较少。本综述旨在确定社区居民和躯体或精神障碍患者群体中自杀意念(SI)/自杀行为(SB)和道德低落的原创研究。
我们采用系统方法,遵循 PRISMA 指南,通过四个主要电子数据库(PubMed/MEDLINE、Scopus、Science Direct 和 PsychINFO)搜索 1980 年 1 月至 2021 年 6 月发表的相关标题/摘要。我们纳入了明确提及 SI/SB 与道德低落之间潜在关联的原创研究。
共有 18 项研究符合纳入标准。综合分析结果表明,道德低落可与广泛人群(社区居民、躯体或精神障碍患者)的 SI/SB 相关,并导致显著更高的自杀风险(在经历经济困难或孤立的社区居民中,发现比值比>6)。此外,道德低落本身(大约一半的道德低落患者不符合情感障碍的标准,也没有临床抑郁)或与抑郁一起被确定为 SI/SB 的主要危险因素。关于从 SI 到 SA 进展的关键问题,在“意念到行动”框架中,一些作者发现道德低落和过度警觉的相互作用可能是这一进展的有用预测因子,而另一些作者发现抑郁本身足以区分企图自杀者和非企图自杀者,或与关机(无助和低正性情绪)的相互作用。
这些结果强调了将道德低落识别为自杀的独立危险因素的可能性。在精神障碍患者中,道德低落与 SI/SB 的关联可能是跨疾病的。总体而言,从临床意义的角度来看,我们的研究结果强调:i. 评估道德低落可能有助于更全面地检测自杀风险。这在急诊科(ED)中尤为重要,因为那里通常会收治不同类型的人群,而且经常难以确定临床抑郁的诊断。ii. 此外,由于无意义被认为是道德低落的一个亚成分,因此以意义为中心的心理治疗方法被证明是有效的,并且可以在 ED 与患者首次接触时就开始实施。需要进一步的研究来证实这些发现。